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ABSTRACT
Background and Objective: The results of tuberculin
skin tests (TST) and QuantiFERON TB-Gold In-Tube
(QFT-GIT) assays were compared in close contacts
of patients with multidrug-resistant tuberculosis
(MDR-TB).
Methods: Close contacts of patients with bacterio-
logically confirmed MDR-TB (n = 101) were assessed.
Most contacts were members of the households of
patients, and 79 (78.2%) had received Bacille Calmette-
Guerin (BCG) vaccination. Samples from each contact
were tested using theTST and theQFT-GIT assay on the
same day, and the concordance between these results
was assessed using kappa (k) coefficients.
Results: Forty-eight subjects (47.5%) showed positive
responses on TST, using a 10-mm induration cut-off,
and 54 (53.5%) were positive for the QFT-GIT assay. Of
the 48 individuals who were TST positive, 34 (70.8%)
were positive for the QFT-GIT assay. Of the 53 subjects
who were TST negative, 33 (62.5%) were negative for
the QFT-GIT assay. The overall agreement between the
two tests (k coefficient) was 0.33. The k coefficient was
higher in the 22 subjects who had not received BCG
vaccination (k = 0.48) than in the 79 subjects who had
received BCG vaccination (k = 0.29).
Conclusion: The TST and QFT-GIT assays showed
poor correlation in close contacts of patients with
MDR-TB, especially those contacts who had received
BCG vaccination.
Key words: close contact, interferon-g assay, multi-
drug-resistant tuberculosis, tuberculin skin test.
INTRODUCTION
Multidrug-resistant tuberculosis (MDR-TB), defined
as resistance to at least isoniazid and rifampicin, now
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SUMMARY AT A GLANCE
There was a discrepancy between results of TSTs
and QFT-GIT assays in close contacts of patients
with multidrug-resistant tuberculosis, particularly
those who had received BCG vaccination. These
findings were similar to those from studies report-
ing poor correlation between these tests in close
contacts of South Korean patients with drug-
susceptible tuberculosis.
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affects all regions of the world and has become a
serious threat to public health. In South Korea, which
is an intermediate TB-burden country, 2.7% of
patients newly diagnosed with TB in 2004 were found
to have MDR-TB,1 and the overall rate of treatment
success in these patients was only 45.3%.2 Because
about half of MDR-TB patients have unfavourable
treatment outcomes and MDR-TB can continue to
spread in the community, assessment of infection in
close contacts of these patients is important in order
to stop further transmission and to prevent new cases
of MDR-TB.
In addition to the tuberculin skin test (TST), which
until recently has been the only method for detecting
TB infection, interferon-gamma release assays (IGRA)
have emerged as a new tool for screening for TB infec-
tions, and both these tests have been used in investi-
gations of contacts of patients with infectious TB.
However, guidelines on the use of TST or IGRA for
detecting latent tuberculosis infection (LTBI) vary.3–5
Several South Korean studies comparing these assays
in close contacts of patients with drug-susceptible TB
have shown that these two tests generally show poor
correlation.6–8
The relative transmissibility of MDR-TB and drug-
susceptible TB to close contacts of patients infected
with these bacteria remains unclear.9–12 Moreover, few
studies have compared the results fromTST and IGRA
in close contacts of patients withMDR-TB.13We there-
fore compared TST and IGRA as methods for screen-
ing for LTBI among close contacts of patients with
confirmed MDR-TB.
METHODS
Subjects
A multicentre prospective cohort study to identify
close contacts of patients with MDR-TB who have
LTBI and active TB has started at 26 referring hospi-
tals throughout South Korea since March 2010 and is
expected to be completed in December 2013. Index
patients were defined as those diagnosed with bac-
teriologically confirmed pulmonary MDR-TB within
6 months of the time of enrolment, regardless of
positivity on sputum acid fast bacilli (AFB) smear
testing. Close contacts were categorized into two
groups: (i) close household contacts, defined as indi-
viduals who had resided in the same house as the
index patient for at least 1 month during the
6 months prior to the index patient commencing
anti-TB treatment; and (ii) close non-household con-
tacts, defined as individuals who had spent more
than eight hours per day at work with the index
patient, had shared breathing space with the index
patient, or were in regular, prolonged contact with
the index patient.14 Close contacts who had been
diagnosed with or were being treated for active TB at
the time of enrolment were excluded.
For each close contact, demographic data and clini-
cal history were recorded, and a physical examina-
tion, chest radiography and/or sputum AFB smear/
culture (if they produced sputum) were performed.
TST andQuantiFERONTB-Gold In-Tube assays (QFT-
GIT; Cellestis Ltd, Carnegie, Victoria, Australia) were
performed for each individual, at the same time on
the day of enrolment, according to the study protocol.
After enrolment, subjects will be followed-up every
6 months for 2 years.
The subjects for this study were selected from this
cohort of contacts, and their baseline characteristics
and results from the TST and QFT-GIT assays were
analysed. The clinical protocol was approved by
the institutional review board, and written informed
consent was obtained from all patients. The trial
has been registered with the Clinical Research Infor-
mation Service of the Republic of Korea as
KCT0000004.
Tuberculin skin tests
TSTs were performed by intra-dermal injection of
two tuberculin units of purified protein derivative
(PPD) RT23 (Statens Serum Institute, Copenhagen,
Denmark) into the forearm using the Mantoux tech-
nique.15 Reactions were evaluated 48 to 72 h after
injection, with positive results being defined as indu-
rations 10 mm in transverse diameter.
QuantiFERON-TB Gold In-Tube assay
The QFT-GIT assay was performed in two stages,
according to the manufacturer’s instructions. One
millilitre aliquots of blood were drawn directly into
three evacuated blood collection tubes, one contain-
ing heparin alone (negative control), one containing
T cell mitogen (positive control) and one contain-
ing Mycobacterium tuberculosis-specific antigens,
including early secreted antigenic target 6 (ESAT-6)
and culture filtrate protein 10 (CFP-10) (TB antigen
tube). Following overnight incubation, 200 mL of
plasma was removed from each well, and the concen-
tration of interferon-gamma (IFN-g) was determined
by enzyme-linked immunosorbent assay, with a posi-
tive response being defined as an antigen-negative
IFN-g concentration 0.35 IU/mL.16
Statistical analyses
Concordance between the results fromTSTs andQFT-
GIT assays was assessed using kappa (k) coefficients,
with k > 0.75 being defined as excellent agreement,
k < 0.4 as poor agreement and k between 0.4 and 0.75
as fair to good agreement.6 All statistical analyses
were performed using SPSS version 12.0 software
(SPSS Inc., Chicago, IL, USA).
RESULTS
Characteristics of the subjects
The study cohort consisted of 101 contacts, from
whom 47 were contacts of 32 TB patients who had a
K-W Jo et al.1126
© 2012 The Authors
Respirology © 2012 Asian Pacific Society of Respirology
Respirology (2012) 17, 1125–1130
positive AFB sputum smear, and 54 were contacts
of 35 TB patients who had a negative AFB sputum
smear. Twenty-six (38.8%) of 67 patients with
MDR-TB showed cavitary disease on chest X-ray.
The mean age of the 101 contacts was 39.9  17.7
years, 69 (68.3%) were females, 79 (78.2%) had
received Bacille Calmette-Guerin (BCG) vaccination
and 95 (94.1%) were close household contacts
(Table 1).
Of these 101 contacts, 48 (47.5%) were positive, and
53 (52.5%) were negative by TST. Moreover, 54 (53.5%)
were positive, and 47 (46.5%) were negative by QFT-
GIT assay. Of the 48 TST positive subjects, 38 (79.2%)
had received BCG vaccination (Table 2). The median
IFN-g concentration for subjects whowere positive by
QFT-GIT assay was 0.65 IU/mL (range 0.35 to 15.24)
(Fig. 1). Among the four contacts with a previous
history of TB, one was positive by TST, and two were
positive by QFT-GIT assay.
Comparison between the TST and
QFT-GIT results
Sixty-eight individuals (67.3%) were positive either by
TST or QFT-GIT assay, and 34 (33.7%) were positive
by both tests. Of the 48 TST positive individuals, 34
(70.8%) were positive by QFT-GIT assay, whereas of
the 53TST negative subjects, 33 (62.5%) were negative
by QFT-GIT assay. The overall agreement between
results from theTST andQFT-GIT assays in close con-
tacts (k coefficient) was 0.33.
Assessment of the agreement between the TST and
QFT-GIT results in the 79 BCG-vaccinated individu-
als gave a k coefficient of 0.29. In contrast, the cor-
relation between these two tests was greater in the
22 contacts who had not been vaccinated (k = 0.48;
Table 3). There was no significant difference in the
level of correlation between the two tests among
close contacts of index patients who were positive or
negative on sputum AFB smear testing (Table 4). The
level of agreement was also similar when analyzed
according to degree of contact (i.e. household vs
non-household).
Table 1 Clinical characteristics of 101 close contacts of
patients with multidrug-resistant tuberculosis
Characteristic Number (%)
Age, years 39.9  17.7*
Gender
Males 32 (31.7)
Females 69 (68.3)
BMI, kg/m 22.9  4.0
Current smokers 24 (23.8)
Previous history of TB 4 (4.0)
BCG vaccination 79 (78.2)
Co-morbidity
Hypertension 8 (7.9)
Diabetes mellitus 5 (5.0)
Angina 2 (2.0)
Chronic renal failure 0 (0)
Arrhythmia 2 (2.0)
Degree of contact
Close household 95 (94.1)
Close non-household 6 (5.9)
Data are *means  SD or number (%) of subjects.
BCG, Bacille Calmette-Guerin; BMI, body mass index;
TB, tuberculosis.
Table 2 Results of tuberculin skin tests and QFT-GIT
assays in close contacts of patients with multidrug-
resistant tuberculosis
BCG vaccination
Vaccinated
(n = 79)
Unvaccinated
(n = 22)
TST (10 mm cut-off)
Positive (n = 48) 38 (48.1%) 10 (45.5%)
Negative (n = 53) 41 (51.9%) 12 (54.5%)
TST (5 mm cut-off)
Positive (n = 67) 50 (74.6%) 17 (25.4%)
Negative (n = 34) 29 (85.3%) 5 (14.7%)
QTF-GIT assay
Positive (n = 54) 38 (48.1%) 16 (72.7%)
Negative (n = 47) 41 (51.9%) 6 (27.3%)
Data are numbers (%) of subjects. BCG, Bacille
Calmette-Guerin; QFT-GIT, QuantiFERON-TB Gold
In-Tube; TST, tuberculin skin test.
Figure 1 Dot plot showing individual results of tuberculin
skin tests and QuantiFERON TB-Gold In-Tube (QFT-GIT)
assays in close contacts of patients with multidrug-
resistant tuberculosis. The dashed line indicates a cut-off
of 0.35 IU/mL for interferon-gamma. All points below
zero for the QFT-GIT assay have been assigned a value of
zero. The borderline zone is defined as the variation
around the cut-off point (0.2 to 0.7 IU/mL for the QFT-GIT
assay).
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Incidence of tuberculosis during
the study period
After a median follow-up period of 6 months (range
0–12), none of the 101 contacts had developed active
TB.
DISCUSSION
We have assessed the degree of correlation between
TSTs and QFT-GIT assays in close contacts of patients
with MDR-TB. This is the first study that has com-
pared the results from these two tests in close con-
tacts of MDR-TB patients in South Korea. The most
important finding from this study was that these
assays showed poor correlation in close contacts of
patients with MDR-TB, which is consistent with the
findings from South Korean studies of close contacts
of patients with drug-susceptible (DS)-TB.6–8
Studies assessing the prevalence of active TB in
close contacts of patients with MDR-TB have yielded
contradictory results. Thus, of the 4503 household
contacts of Peruvian patients with MDR-TB, 359
(8.0%) had active TB during a 4-year follow up.9
Among these, 90.9% (129/142) were confirmed as
havingMDR-TB.9 Kritski et al. reported similar results
showing that 17 of 218 (7.8%) previously healthy close
contacts of 64 MDR-TB patients in Rio de Janeiro
developed TB.10 Among 13 isolates, six (46%) showed
susceptibility patterns identical to those of the index
cases.10 In Israel, however, none of 476 close contacts
of patients with MDR-TB developed active TB.11
Besides, one study in Brazil showed that household
contacts of patients with DS-TB and MDR-TB had
comparable rates of TB infection and progression to
active TB. That is, six of 157 contacts of MDR-TB
patients (4%) and 11 of 251 contacts of DS-TB patients
(4%) were found to have active TB.12
Since the infectivity of MDR-TB may differ from
that of DS-TB, it was unclear whether discrepancies in
the correlation between TST and QFT-GIT results
among contacts of patients with DS-TB6–8 might also
apply to contacts of South Korean patients withMDR-
TB. This study showed that the overall rates of posi-
tivity and levels of inconsistency between these two
tests, in contacts of patients with MDR-TB, were
similar to those in contacts of patients with DS-TB.6–8
The infectivity of MDR-TB is associated with the
overall incidence of TB and the existence of national
programmes to detect patients and contacts. That is,
investigations of contacts of MDR-TB patients in
areas with an overall low incidence of DS-TB and an
effective national programme have shown that the TB
burden among contacts was low,11,17 with contrasting
results being observed in areas of high incidence of
DS-TB and/or an ineffective or non-existent national
programme.9,10 Likewise, the level of agreement
between TSTs and QFT-GIT assays has been reported
to generally coincide with the national prevalence of
Table 3 Agreement between results of tuberculin skin tests and QFT-GIT assays in close contacts of index patients
according to BCG vaccination status
TST/QFT-GIT results
Kappa P value+/+ +/- -/+ -/-
TST (10 mm cut-off)
BCG vaccinated (n = 79) 24 14 14 27 0.29 0.01
BCG unvaccinated (n = 22) 10 0 6 6 0.48 0.009
TST (5 mm cut-off)
BCG vaccinated (n = 79) 29 21 9 20 0.25 0.021
BCG unvaccinated (n = 22) 15 2 1 4 0.64 0.003
Data are numbers of patients. BCG, Bacille Calmette-Guerin; QFT-GIT, QuantiFERON-TB Gold In-Tube; TST, tuberculin
skin test.
Table 4 Agreement between results of tuberculin skin tests and QFT-GIT assays in close contacts of index patients with
either positive or negative sputum AFB smear results
TST/QFT-GIT results
Kappa P value+/+ +/- -/+ -/-
TST (10 mm cut-off)
Sputum AFB smear (+) (n = 47) 15 8 8 16 0.32 0.029
Sputum AFB smear (-) (n = 54) 19 6 12 17 0.34 0.01
TST (5 mm cut-off)
Sputum AFB smear (+) (n = 47) 18 13 5 11 0.24 0.081
Sputum AFB smear (-) (n = 54) 19 6 12 17 0.42 0.002
Data are number of patients. AFB, acid fast bacilli; QFT-GIT, QuantiFERON-TB Gold In-Tube; TST, tuberculin skin test.
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TB.8,18,19 Taken together, these results suggest that the
overall rate of positivity and degree of correlation
between TSTs and QFT-GIT assays in contacts of
MDR-TB patients are similar to those in contacts of
DS-TB patients. Further studies are needed to test this
hypothesis.
This study showed that previous BCG vaccination
significantly affected the concordance between
the two tests, which is in agreement with earlier
reports.13,20 A higher k coefficient was observed for the
22 subjects who had not received BCG vaccination
than for the 79 subjects who had received BCG vacci-
nation, suggesting that the PPD antigen used in TSTs
leads to false-positive results in individuals who had
received BCG vaccination. In South Korea, children
receive BCG vaccination at birth; until 1997, TST non-
responders were re-vaccinated at the age of 12 or
13 years. All 14 individuals who were positive by TST
and negative by QFT-GIT assay had been vaccinated,
and their mean age was about 13 years less than that
of the entire study cohort. Although the exact number
of subjects who had been re-vaccinated could not be
determined, the present findings indicate that incon-
sistency in the results for these individuals was likely
due to the confounding effects of previous BCG
vaccination, rather than possible mycobacterial
infection.
The discrepancy observed in this study may be due
to the inaccuracy of the QFT-GIT assay and/or TSTs.
The ESAT-6, CFP-10 and TB7.7 peptides, which are
used in IGRA, are not representative of the entire
spectrum of antigenicity ofMycobacterium tuberculo-
sis.21,22 In addition, short-termwithin-subject variabil-
ity has been reported for IGRA, with variations around
the cut-off point for the QFT-GIT assay (0.2 to 0.7 IU/
mL) being a ‘borderline zone’, such that results falling
in this range should be interpreted with caution.23 In
the present study, 19 of 101 close contacts (18.8%) had
QFT-GIT results in this range. Of 20 subjects whowere
negative by TST and positive by QFT-GIT assay, only
five had QFT-GIT results within this range. This sug-
gests that the findings in this group were mainly due
to greater sensitivity of the QFT-GIT assay and a
poorer sensitivity of TST for detecting TB infections,
incorrect administration of TSTs, imprecise interpre-
tation of reactions, very old TB infection, anergy due
to natural waning of immunity or a viral illness.24
TB patients with positive sputum AFB smears are
generally considered to have a higher infectivity than
patients who are AFB smear negative. However, the
present study showed that test results among contacts
were similar, irrespective of the sputum AFB smear
results for index patients. Similarly, there were no sig-
nificant differences in the results for close household
and non-household contacts, although the number of
close non-household contacts was likely too small to
reveal any significant differences. In most cases, a
contact investigation was performed immediately
after the termination of contact. However, the expo-
sure time was expected to be substantial since the
majority of cases were close household contacts.
The cohort study, from which the subjects were
drawn, was originally designed to investigate the inci-
dence of TB in close contacts of patients with MDR-
TB. To date, however, none of these contacts, even
those who were positive by both assays, has devel-
oped active TB. Moreover, although close contacts
who had been diagnosed with or were being treated
for active TB at the time of enrolment were excluded,
as specified by the cohort study protocol, there
were no close contacts who met these criteria at
screening. However, these 101 subjects will be moni-
tored for an additional 2 years to ascertain whether
they develop active TB and, if they do, the findings
for those subjects will be compared with those for
subjects who do not develop activeTB. As specified by
the Korean TB guidelines, no close contacts received
chemoprophylaxis.
Since South Korea is a country with a low burden of
human immunodeficiency virus (HIV) infection, HIV
testing was not performed for these subjects. In addi-
tion, none of the close contacts had risk factors for
HIV infection or showed signs that would suggest a
clinical suspicion of HIV infection.
The KoreanTB guidelines recommend aTST cut-off
10 mm for non-HIV-infected subjects in South
Korea, where the incidence of HIV infection is low,
and BCG vaccination is mandatory.When a cut-off of
5 mm, rather than 10 mm, was used in this study, the
k coefficient for agreement between the two tests
increased from 0.48 to 0.64 in subjects who had not
received BCG vaccination, and from 0.34 to 0.42 in
close contacts of patients with negative AFB sputum
smears. These findings suggest that a 5 mm cut-off
may provide a better indication of TB infection when
screening contacts in South Korea.
This study had several limitations. Because it was
part of a multicentre trial, TSTs were performed at
different centres, depending on the subject’s place of
residence. Therefore, the TST results were read by
several different individuals, which might have
resulted in inconsistency. In addition, all close con-
tacts of index patients could not be investigated,
either because they chose not to participate or
because of their place of residence. Therefore, the
study populationmay not have been representative of
all close contacts of index patients.
In conclusion, TSTs and QFT-GIT assays showed
inconsistent results in close contacts of MDR-TB
patients in South Korea, which is similar to the find-
ings in close contacts of DS-TB patients.
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